Swiss Re AG
XMUN:SR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Swiss Re AG
XMUN:SR9
|
CH |
|
C
|
CBRE Group Inc
XMUN:RF6
|
US |
|
P
|
Papa John's International Inc
XMUN:PP1
|
US |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
I
|
IMCD NV
SWB:INX
|
NL |
|
D
|
Draganfly Inc
F:3U8
|
CA |
|
E
|
eBay Inc
XMUN:EBA
|
US |
|
F
|
Fifth Third Bancorp
XMUN:FFH
|
US |
Wall St Price Targets
SR9 Price Targets Summary
Swiss Re AG
According to Wall Street analysts, the average 1-year price target for SR9 is 145.65 EUR with a low forecast of 126.69 EUR and a high forecast of 184.85 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SR9's stock price target?
Price Target
145.65
EUR
According to Wall Street analysts, the average 1-year price target for SR9 is 145.65 EUR with a low forecast of 126.69 EUR and a high forecast of 184.85 EUR.
What is the Revenue forecast for Swiss Re AG?
Projected CAGR
7%
Over the last 14 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 8 years is 7%.
What is the Net Income forecast for Swiss Re AG?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 8 years is 6%.
